Evidence map›Paper›PMID 40935721›Full record

ArticleBritish journal of anaesthesia2025

Propofol is in the air: can exhaled gas monitoring illuminate intravenous dosing?

Kai Kuck, Cyrill Hornuss

Abstract readEditorial
In one paragraph

Article in British journal of anaesthesia, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Kai KuckDepartment of Anesthesiology, University of Utah, Salt Lake City, UT, USA.
Cyrill HornussHexal AG/Sandoz Biopharmaceuticals, Holzkirchen, Germany. Electronic address: c.hornuss@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Exhaled propofol monitoring has the potential to guide i.v. anaesthesia in a manner analogous to end-tidal monitoring of inhalation anaesthetics. Early proof-of-concept studies demonstrated the detection of propofol in breath, but adoption into routine clinical practice has been limited by the lack of compact, accurate, and rapid sensors, together with incomplete understanding of the pharmacokinetics of exhaled propofol across diverse patient populations. In this issue, a novel photoacoustic sensor that demonstrates strong correlation with mass spectrometry, the current gold standard for exhaled propofol detection, while offering reduced complexity and size, is described. This technology could facilitate broader investigation of exhaled propofol in clinical settings, potentially informing strategies to improve anaesthesia delivery and patient outcomes during i.v. anaesthesia.

Indexed as

Anesthetics, IntravenousPropofolBreath TestsExhalationHumansPhotoacoustic TechniquesAnesthetics, IntravenousPropofolexhaled breath monitoringintravenous anaesthesiapatient safetypharmacokineticsphotoacoustic sensorpropofoltarget-controlled infusion

Identifiers

PMID40935721
PMCPMC12597357

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.